MedPath
HSA Approval

DBL EPHEDRINE SULFATE INJECTION 30 mg/ml

SIN02734P

DBL EPHEDRINE SULFATE INJECTION 30 mg/ml

DBL EPHEDRINE SULFATE INJECTION 30 mg/ml

May 6, 1989

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

R03CA02

ephedrine

Manufacturer Information

PFIZER PRIVATE LIMITED

Siegfried Hameln GmbH

Active Ingredients

EPHEDRINE SULFATE

30 mg/ml

Ephedrine

Documents

Package Inserts

DBL EPHEDRINE SULFATE INJECTION PI.pdf

Approved: January 15, 2020

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL EPHEDRINE SULFATE INJECTION 30 mg/ml - HSA Approval | MedPath